Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: Results of CIBIS II

Henry Krum, Michael John Bailey, Wilfried Meyer, Patricia Verkenne, Henry Dargie, Phillipe Lechat, Stefan D Anker

Research output: Contribution to journalArticleResearchpeer-review

26 Citations (Scopus)


BACKGROUND: HMG-CoA reductase inhibitors (statins) are widely prescribed in patients with established systolic chronic heart failure (CHF). However, there is considerable controversy regarding their benefit in this setting. We therefore conducted a post-hoc analysis of outcomes according to statin use within the Second Cardiac Insufficiency Bisoprolol Study of the beta-blocker, bisoprolol, in NYHA classes III-IV systolic CHF patients (left ventricular ejection fraction
Original languageEnglish
Pages (from-to)28 - 34
Number of pages7
Issue number1
Publication statusPublished - 2007

Cite this